Table 1.
Non-Small Cell Lung Cancer | Small Cell Lung Cancer | |||||
---|---|---|---|---|---|---|
Weighted Patients | Unweighted | Weighted Patients | Unweighted | |||
(n = 31,864) | Patients | (n = 6,288) | Patients | |||
No. | % | (n = 340) | No. | % | (n = 144) | |
Age at start of RT (years) | ||||||
Mean | 67 | 63 | ||||
Median | 66 | 63 | ||||
Interquartile range | 59–75 | 59–66 | ||||
Sex | ||||||
Male | 16,210 | 50.9 | 179 | 3,053 | 48.6 | 73 |
Female | 15,654 | 49.1 | 161 | 3,235 | 51.5 | 71 |
Race | ||||||
White | 24,823 | 77.9 | 261 | 5,378 | 85.5 | 121 |
Black/African-American | 5,313 | 16.7 | 59 | 730 | 11.6 | 18 |
Asian | 665 | 2.1 | 7 | — | — | 0 |
Other/Unspecified | 1,063 | 3.3 | 13 | 180 | 2.9 | 5 |
Ethnicity | ||||||
Hispanic | 1,512 | 4.8 | 18 | 189 | 3.0 | 5 |
Not Hispanic/Unspecified | 30,352 | 95.2 | 322 | 6,099 | 97.0 | 139 |
Marital Status | ||||||
Married | 16,458 | 51.6 | 174 | 3,730 | 59.3 | 84 |
Single | 10,762 | 33.8 | 111 | 2,088 | 33.2 | 46 |
Not specified / Unknown | 4,643 | 14.6 | 55 | 469 | 7.5 | 14 |
Primary payment method | ||||||
Medicare | 17,418 | 54.7 | 173 | 2,266 | 36.0 | 45 |
Private Insurance | 5,998 | 18.8 | 68 | 2,208 | 35.1 | 55 |
Health Maintenance Organization | 3,944 | 12.4 | 35 | 880 | 14.0 | 16 |
Medicaid | 2,154 | 6.8 | 22 | 597 | 9.5 | 14 |
Government Insurance | 1,345 | 4.2 | 24 | 295 | 4.7 | 11 |
Self-Pay | 232 | 0.7 | 5 | 42 | 0.7 | 3 |
Not specified | 773 | 2.4 | 13 | |||
Stratum | ||||||
Academic | 5,192 | 16.3 | 112 | 731 | 11.6 | 52 |
Large Nonacademic (>3 linacs) | 6,838 | 21.5 | 104 | 1,152 | 18.3 | 46 |
Medium Nonacademic (2 linacs) | 9,255 | 29.0 | 52 | 2,496 | 39.7 | 25 |
Small Nonacademic (1 linac) | 10,580 | 33.2 | 72 | 1,909 | 30.4 | 21 |
Census Region | ||||||
Northeast | 5,043 | 15.8 | 48 | 791 | 12.6 | 17 |
Midwest | 8,012 | 25.1 | 92 | 1,918 | 30.5 | 49 |
South | 11,748 | 36.9 | 125 | 2,049 | 32.6 | 46 |
West | 7,061 | 22.2 | 75 | 1,531 | 24.4 | 32 |
Karnofsky Performance Score | ||||||
60 | 1,728 | 5.4 | 18 | 133 | 2.1 | 4 |
70 | 5,166 | 16.2 | 54 | 975 | 15.5 | 19 |
80 | 9,620 | 30.2 | 108 | 2,017 | 32.1 | 49 |
90 | 10,542 | 33.1 | 111 | 2,384 | 37.9 | 55 |
100 | 4,760 | 14.9 | 48 | 780 | 12.4 | 17 |
Unknown (>=60) | 46 | 0.1 | 1 | |||
Smoking Status | ||||||
Never smoked | 1,879 | 5.9 | 16 | 14 | 0.2 | 1 |
Current smoker | 14,010 | 44.0 | 149 | 3,488 | 55.5 | 76 |
Former smoker (quit ≤1 year ago) | 3,650 | 11.5 | 41 | 1,059 | 16.8 | 27 |
Former smoker (quit >1 year and | ||||||
≤10 years ago) | 4,253 | 13.3 | 50 | 1,086 | 17.3 | 23 |
Former smoker (quit >10 years ago) | 7,383 | 23.2 | 73 | 577 | 9.2 | 14 |
Former smoker (quit period unknown) | 464 | 1.5 | 7 | |||
Unknown smoking status | 224 | 0.7 | 4 | 64 | 1.0 | 3 |
Tumor Histology | ||||||
Squamous cell | 11,094 | 34.8 | 120 | |||
Adenocarcinoma | 10,213 | 32.1 | 108 | |||
Large-cell | 967 | 3.0 | 11 | |||
NSCLC, NOS | 8,863 | 27.8 | 94 | |||
Other | 483 | 1.5 | 5 | |||
Unknown | 244 | 0.8 | 2 | |||
Small-cell/oat cell | 6,235 | 99.2 | 141 | |||
Mixed histology (SCLC and NSCLC) | 53 | 0.8 | 3 | |||
Disease Stage | ||||||
1 | 53 | n/a | ||||
II | 39 | n/a | ||||
III | 211 | n/a | ||||
Unknown | 37 | n/a |
Abbreviations: QRRO, Quality Research in Radiation Oncology; RT, radiation therapy; linacs, linear accelerators; NSCLC, NOS, non-small cell lung cancer not otherwise specified; SCLC, small cell lung cancer; n/a, not applicable (all small cell lung cancer was considered limited stage);.